RxDoctor Payments Data

Harishankar Gopakumar, MD

Gastroenterology · Boston, MANPI 1356605703

Payments from drug & device makers

What this record shows

This record is dominated by grants: $35,388 of the $38,504 with a category attached, or 91.9%. Boston Scientific accounts for 92.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $36,570, more than ten times the $162 reported in 2019. Among gastroenterology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,504in general payments, 2019–2025

Across 42 payments — averaging $916.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$36K
  • Olympus Corporation Of The Americas$1K
  • AbbVie$332
  • Steris Corporation$243
  • Medtronic$201
  • Fujifilm Healthcare Americas Corporation$160
  • plus $689 from 8 others

What the payments were for

  • Grants$35,38892%
  • Travel & lodging$1,0533%
  • Food & beverage$2,0635%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,504 in reported general payments places this provider in the 90th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$32,973
Medicare patients
105
Services billed
250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole45$458
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl26$336
Pantoprazole Sodium15$172

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →